Finding solutions in a strained supply chain
The pharmaceutical supply chain has experienced lengthy delivery delays due to the events of the past two years, while increases in home-based clinical trials and direct-to-patient services have seen demand increase for quality packaging products. The market has had to flex and adapt to changing requirements, while extended distribution durations have led to further bottlenecks.
In this Pharma Logistics IQ report, brought to you in association with Topa Thermal, we look at the role secured pharma packaging can play in protecting the integrity of drug products and facilitates authentication, and how the global pandemic has inspired innovation in packaging solutions.
Speaking to experts from the likes of MSD, Bayer and Topa Thermal, this report looks at the challenges facing manufacturers and the issues affecting pharmaceutical product delivery across the globe.
Download this report to find out:
- How the global pandemic transformed attitudes and approaches to packaging solutions
- What manufacturers and 3PLs should do to ensure distribution channels remain open
- Why pre-qualified thermal packaging offers a winning solution for pharma products